The Missing Metric: Smartphone-Powered Kidney Testing to Improve Health Plan Risk Assessment and Quality Measures

A simple urine test can provide early warning for chronic kidney disease (CKD) before it becomes symptomatic. However, the albumin-to-creatinine ratio (ACR) test rates for the 75 million at-risk Americans are as low as 20% on average, allowing millions of cases to go undiscovered. With CKD costing Medicare over $120 billion annually, the lack of detection is also extremely costly. Without intervention, CKD will continue to be a burden on the American health system.

In this paper, you’ll learn about current care gaps, why ACR is a critical data point for health plans, and how smartphone-powered home testing can help raise adherence, improve risk assessment and quality metrics, and reduce the cost of care.

You’ll also be introduced to Minuteful Kidney, the first and only FDA-cleared, smartphone-powered at-home ACR test. By removing the barriers to testing, the service engages members and dramatically boosts test adherence. 


Download the Whitepaper to learn more

Please keep me informed on products and services from Healthy.io
This Offer Has Expired

By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Healthy.io products, services, and events. The data sent will be processed in Canada and provided to Healthy.io who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal.